Sevim Oezguer Bruederle

Title: Sevim Oezguer Bruederle: Innovator in Bispecific Antibodies

Introduction

Sevim Oezguer Bruederle is a prominent inventor based in Frankfurt-am-Main, Germany. She has made significant contributions to the field of biomedicine, particularly in the development of multispecific binding proteins. Her innovative work has the potential to impact the treatment of autoimmune diseases.

Latest Patents

Sevim holds a patent for CD28/OX40 bispecific antibodies. This patent describes multispecific binding proteins that include a first antigen binding domain (ABD) with binding specificity to CD28 and a second ABD with binding specificity to OX40. The patent also outlines methods for treating autoimmune diseases using these multispecific binding proteins. She has 1 patent to her name.

Career Highlights

Sevim Oezguer Bruederle is currently employed at Sanofi, a global biopharmaceutical company. Her role at Sanofi allows her to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Throughout her career, Sevim has worked alongside notable colleagues such as Gerald Beste and Yanik Bruynooghe. These collaborations have further enhanced her research and innovation in the field of bispecific antibodies.

Conclusion

Sevim Oezguer Bruederle is a trailblazer in the development of bispecific antibodies, with a focus on treating autoimmune diseases. Her contributions to the field are invaluable, and her work continues to inspire future innovations in biomedicine.